Merck will partner with Chinese biotech Abbisko Therapeutics to market and sell the bone-tumor treatment pimicotinib globally, expanding its commercialization rights for the drug beyond Asia. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback